Company / Current Assets per Share
Apellis Pharmaceuticals, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$8.15
FY2025
5-year range
$6.60 / $10.82
FY2021-FY2025
Trend
+23.5%
vs FY2024
Sector context
#90 of 210
Health Care
What the data says
At $8.15, Apellis Pharmaceuticals, Inc.'s current assets per share ranks #90 of 210 in the Health Care sector. Current Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $8.15.
Based on SEC 10-K filings.
8.15 in FY2025 with a 5-year CAGR of -10.7%.
Improved from $6.92 to $8.15 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- -10.7%
- 10-Year CAGR
- -
Sector benchmark
#90 of 210 in Health CareTop 43% of 210This company $8.15 Sector average $170.65
▼
-95.2% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 23.5% year-over-year.
- Ranks #90 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.15 | +23.5% |
| FY2024 | $6.60 | -4.6% |
| FY2023 | $6.92 | -6.2% |
| FY2022 | $7.38 | -31.8% |
| FY2021 | $10.82 | -24.5% |
| FY2020 | $14.35 | +139.3% |
| FY2019 | $6.00 | +61.1% |
| FY2018 | $3.72 | -71.6% |
| FY2017 | $13.12 | +304.1% |
| FY2016 | $3.25 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026